Product Reports Resources Pricing Login Book a demo

NantHealth

Health Tech & Medtech · Culver City, United States · Founded 2007 · IPO 2016

Healthcare company providing an evidence-based platform for healthcare diagnostics

Valuation $328M
Revenue $67M

Investors

6 investors on NantHealth's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage
Kuwait Investment Authority
BlackBerry
Celgene
Verizon Ventures
Blackstone
Bristol-Myers Squibb

Global footprint

Where NantHealth has talent and traffic

Workforce by country
🇺🇸 United States · Culver City HQ
Book a demo for the full country breakdown
Web traffic by country
46K monthly visits
across markets
🇺🇸 United States95.2%
🇮🇳 India2%
🇨🇴 Colombia1.1%
🇵🇭 Philippines0.7%
🇧🇪 Belgium0.2%
Top 5 markets shown

Talent graph

The shape of NantHealth's talent

Dealroom maps NantHealth's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

24 standout operatorsDealroom-flagged across the org
1 AI specialistpinpointed by name
275 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock NantHealth's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

NantHealth's 11 investments and acquisitions.

Every disclosed deal where NantHealth appeared as a backer or acquirer, 2011–2020. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

11 deals across NantHealth's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        NantHealth's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        11 of 11 deals

        Market sentiment

        What the market is saying about NantHealth

        An AI-synthesized read of the highest-engagement posts about NantHealth on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See NantHealth on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.